• 30+ years experience in the global biopharma industry with deep expertise across CMC, quality, regulatory filing, clinical development, product launch, and entrepreneurial leadership in scaling biotech programs and infrastructure
• Led the clinical and commercial development of 10 innovative biologics, including two global Phase III trials across 30+ countries and the build-out and licensure of 5 GMP manufacturing facilities
• Served as an executive and board member of a publicly listed biotechnology company
• Holds an MS in Biochemical Engineering, an MBA, and an MS in Computer Science
• Recipient of the 2006 U.S. Presidential Green Chemistry Challenge Award